EUVIMEDEUVIMED entdecken
Crossref

Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER + breast cancer

Marina Bacci iD, Nicla Lorito iD, Alfredo Smiriglia iD, Angela Subbiani, Francesca Bonechi, Giuseppina Comito, Ludivine Morriset iD, Rania El Botty iD, Matteo Benelli iD, Joanna I López-Velazco, Maria M Caffarel iD, Ander Urruticoechea iD und 12 weitere

Science Translational Medicine · 28.02.2024 · 16 (736)

DOI: 10.1126/scitranslmed.adf9874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 28.02.2024. Verfasst von Marina Bacci und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting aromatase deprives ER + breast cancers of estrogens and is an effective therapeutic approach for these tumors. However, drug resistance is an unmet clinical need. Lipidomic analysis of long-term estrogen-deprived (LTED) ER + breast cancer cells, a model of aromatase inhibitor resistance, revealed enhanced intracellular lipid storage. Functional metabolic analysis showed that lipid droplets together with peroxisomes, which we showed to be enriched and active in the LTED cells, controlled redox homeostasis and conferred metabolic adaptability to the resistant tumors. This reprogramming was controlled by acetyl-CoA-carboxylase-1 (ACC1), whose targeting selectively impaired LTED survival. However, the addition of branched- and very long–chain fatty acids reverted ACC1 inhibition, a process that was mediated by peroxisome function and redox homeostasis. The therapeutic relevance of these findings was validated in aromatase inhibitor–treated patient-derived samples. Last, targeting ACC1 reduced tumor growth of resistant patient-derived xenografts, thus identifying a targetable hub to combat the acquisition of estrogen independence in ER + breast cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleAromatase InhibitorsPeroxisomesAcetyl-CoA CarboxylaseLipid DropletsCell Line, TumorEstrogensDrug Resistance, Neoplasm

Substanzen

Aromatase InhibitorsAcetyl-CoA CarboxylaseEstrogens

Autor:innen und Institutionen

  • Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
  • Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 rue d'Ulm, 75005 Paris, France.
  • Department of Medical Oncology, Azienda USL Toscana Centro, Hospital of Prato, Via Suor Niccolina Infermiera 20, 59100 Prato, Italy.
  • Biodonostia Health Research Institute, Paseo Dr Begiristain s/n, 20014 San Sebastian, Spain.
  • Ikerbasque, Basque Foundation for Science, Plaza Euskadi 5, 48009 Bilbao, Spain.
  • Gipuzkoa Cancer Unit, OSI Donostialdea-Onkologikoa Foundation, Paseo Dr Begiristain 121, 20014 San Sebastian, Spain.

ORCID-Profile: Marina Bacci, Nicla Lorito, Alfredo Smiriglia, Ludivine Morriset, Rania El Botty, Matteo Benelli, Maria M Caffarel, Ander Urruticoechea, George Sflomos, Luca Malorni, Michela Corsini, Luigi Ippolito, Elisa Giannoni, Icro Meattini, Kristina Havas, Paola Chiarugi, Elisabetta Marangoni, Andrea Morandi

Zitieren

APA

Bacci, M., Lorito, N., Smiriglia, A., Subbiani, A., Bonechi, F., Comito, G., Morriset, L., El Botty, R., Benelli, M., López-Velazco, J. I., Caffarel, M. M., Urruticoechea, A., Sflomos, G., Malorni, L., Corsini, M., Ippolito, L., Giannoni, E., Meattini, I., Matafora, V., …, & Morandi, A. (2024). Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER + breast cancer. Science Translational Medicine, 16(736). https://doi.org/10.1126/scitranslmed.adf9874

Vancouver

Bacci M, Lorito N, Smiriglia A, Subbiani A, Bonechi F, Comito G, et al. Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER + breast cancer. Science Translational Medicine. 2024;16(736). doi:10.1126/scitranslmed.adf9874

BibTeX
@article{Bacci2024,
  author = {Bacci, Marina and Lorito, Nicla and Smiriglia, Alfredo and Subbiani, Angela and Bonechi, Francesca and Comito, Giuseppina and Morriset, Ludivine and El Botty, Rania and Benelli, Matteo and López-Velazco, Joanna I and Caffarel, Maria M and Urruticoechea, Ander and Sflomos, George and Malorni, Luca and Corsini, Michela and Ippolito, Luigi and Giannoni, Elisa and Meattini, Icro and Matafora, Vittoria and Havas, Kristina and Bachi, Angela and Chiarugi, Paola and Marangoni, Elisabetta and Morandi, Andrea},
  title = {Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER + breast cancer},
  journal = {Science Translational Medicine},
  year = {2024},
  volume = {16},
  number = {736},
  doi = {10.1126/scitranslmed.adf9874}
}
Kostenlos starten →